Vaxxas Funding: $100M Raised, Series D (2025)

Vaxxas has raised $100M in total funding. Latest round: Series D. Backed by SPRIM Global Investments, LGT Crestone, OneVentures.

Vaxxas funding overview

Vaxxas has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in August 2025. The round record for Vaxxas runs through 2025; nothing later has been disclosed. Investors on record include SPRIM Global Investments, LGT Crestone, OneVentures, Brandon Capital-Hostplus. 4 distinct backers are named across the disclosed rounds.

Vaxxas at a glance

Total raised
$100M
Latest round
Series D
Latest round date
August 2025
Notable investors
SPRIM Global Investments, LGT Crestone, OneVentures, Brandon Capital-Hostplus

Frequently asked about Vaxxas funding

How much has Vaxxas raised?
Vaxxas has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Vaxxas?
SPRIM Global Investments, LGT Crestone, OneVentures, Brandon Capital-Hostplus are named among the investors backing Vaxxas.
What was the latest Vaxxas funding round?
The most recent disclosed round is a Series D, announced in August 2025.
Where is Vaxxas based?
No headquarters location is disclosed for Vaxxas.
When did Vaxxas last raise?
The last disclosed Vaxxas round closed in August 2025 at Series D.

Totals shown for Vaxxas aggregate every disclosed round on file. To see how that compares, browse the companies and the investors behind them below.

Companies related to Vaxxas (32)

Browse related funding lists (3)

Company funding database · Investor directory · Founder database · Mega-rounds 2026